According to the current analysis of Reports and Data, the global Hemophilia market was valued at USD 12.41 Billion in 2020 and is expected to reach USD 18.75 Billion by the year 2028, at a CAGR of 5.20%.
According to the current analysis of Reports and Data, the global Hemophilia market was valued at USD 12.41 Billion in 2020 and is expected to reach USD 18.75 Billion by the year 2028, at a CAGR of 5.20%. Hemophilia is a rare genetic disorder in which blood doesn’t clot normally because it lacks sufficient blood-clotting proteins known as clotting factors. Among the types of disorders, type A is anticipated to be multiple times more predominant than type B. The global market for hemophilia drugs is growing significantly, owing to the increasing number of hemophilic patients globally. Hemophilia medications are turning out to be one of the essential medicinal products to confine the loss of blood as there is no exact treatment accessible to treat this disorder. Strategies such as geographical expansion by the key market players and new product development are expected to have the most impact on the Hemophilia market. Rising prevalence of the disorder, a significant focus of key market players on the development of gene therapy mechanism, increasing awareness about the disorder, and favorable regulatory scenario, are some of the key factors that support the market growth in the industry.
Access Free sample PDF Copy of the Report (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/2249
However, lack of availability of medicine and high cost of treatment are the factors that limit the market growth over the globe during 2019-2027.
Further key findings from the report suggest:
- Launch of products for hemophilia treatment is expected to support the market growth during the coming years. For instance, in May 2019 FDA approved Roche’s Hemlibra for treatment of hemophilia with or without inhibitors.
- North America dominates the regional hemophilia market and held around 48% market share in 2019.
- Hemophilia B is projected to be the fastest growing segment at a CAGR of 5.7%. However, low availability of treatment for the segment is a major challenge for the market growth for this segment.
- Asia Pacific is expected to show a high growth rate in the hemophilic market and will grow at a CAGR of 6%
- Recombinant coagulation factor concentrate and plasma coagulation factor concentrate are the common options to treat hemophilia and are expected to take up an important position in the global hemophilia market owing to increased prevalence of the von Willebrand Disease.
- On-demand treatment segment is expected to grow at a CAGR of 5.6%.
- Treatment for hemophilia is in the clinical pipeline stage. And the multiple treatments that are underway are expected to significantly improve the quality of life of patients suffering from hemophilia.
- Availability of treatment and lack of awareness about hemophilia is likely to hinder the market growth during the forecast period.
The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years.
For Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2249
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Shire (Takeda), Bayer Healthcare, CSL Behring, Novo Nordisk, Sanofi, Pfizer Inc., among others.
Browse Full Report Description with Research Methodology, Table of Content and Infographics @ https://www.reportsanddata.com/report-detail/hemophilia-market
Hemophilia Market Segmentation:
Type (Revenue, USD Million; 2018–2028)
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
Product (Revenue, USD Million; 2018–2028)
- Plasma derived coagulation factor concentrates
- Factor VIII
- Factor IX
- Factor XII
- Activated prothrombin complex concentrate
- Von Willebrand factor
- Recombinant coagulation factor concentrates
- Factor VIII
- Factor IX
- Von Willebrand factor
- Desmopressin
- Antifibrinolytic agents
- Others
Treatment Type (Revenue, USD Million; 2018–2028)
- Prophylactic
- On-Demand
Therapy Type (Revenue, USD Million; 2018–2028)
- Replacement Therapy
- Immune Tolerance Induction Therapy
- Gene Therapy
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/2249
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore More Industry Research by Reports and Data:
Organ Perfusion System Market Analysis, By Type (Bioreactors Perfusion Systems, Microfluidic Perfusion Systems), By Organ Type (Heart, Lung), By Technique Type (Hypothermic), By Component Type (Perfusion Pumps), By End Use (Clinic), Forecasts to 2026 - Download PDF Brochure
Structural Biology and Molecular Modeling Market Analysis, By Tools (SaaS and Standalone Modeling, Visualization Analysis, Database), By Application (Drug Development, Drug Discovery) and region, Forecasts to 2026 - Download PDF Brochure
Sepsis Diagnostics Market Size, Growth and Analysis, By Product Type (Blood Culture Media, Assays and Reagents, Instruments, Software, Others), By Technology Type (Microbiology, Molecular, Diagnostics, Immunoassays, Flow Cytometry, Microfluidics, Biomarkers), By Pathogens Type (Bacterial, Fungal), By Method Type (Conventional, Automated), By Test Type (Laboratory Tests), By End Use (Hospital, Clinic, Others), Forecasts To 2027 - Download PDF Brochure
Respiratory Syncytial Virus Diagnostic Market Analysis, By Product Type (Kits and Assays, Instruments), By Diagnostic Technology (Immunoassays, Molecular Diagnostic, Monoclonal Antibodies) By End Use (Physician offices, Hospitals), Forecasts to 2026 - Download PDF Brochure
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos